// App-Quantinova.ai

P164 : An emerging role of interferon targeted therapy in mucocutaneous SLE: a prospective real-world evaluation of anifrolumab for refractory cutaneous lupus

Researchers

Presenter

  • Lucy Marie Carter

Principal Investigators

  • Zoe Wigston

  • Philip Laws

  • Edward M Vital

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds School of Medicine, Leeds, United Kingdom

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • MDX1333

  • Interferon

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved